Medicare Part D + GLP-1s: What Changes July 2026
If you're on Medicare and have been watching the GLP-1 revolution from the sidelines, your wait is almost over. The Medicare GLP-1 Bridge program launches July 1, 2026, bringing monthly costs from $349+ down to as little as $50.
What's Actually Changing
Medicare Part D has historically excluded weight loss medications from coverage. The Inflation Reduction Act and subsequent CMS guidance have created new pathways:
The Medicare GLP-1 Bridge (July 1, 2026): This program will cover select GLP-1 medications at approximately $50/month for qualifying beneficiaries. Eligible medications include Zepbound KwikPen, with additional medications expected to be added.
The IRA Negotiated Price (January 2027): Medicare's first batch of negotiated drug prices takes effect, with Ozempic among the included medications. The negotiated price of approximately $274/month represents a significant reduction from the $935+ list price.
Existing OSA Pathway (Available Now): Zepbound's FDA approval for obstructive sleep apnea (OSA) already creates a Part D coverage pathway for beneficiaries with documented sleep apnea. This doesn't require waiting until July — ask your doctor about the OSA indication now.
Who Qualifies for the Medicare GLP-1 Bridge
| Requirement | Details |
|---|---|
| BMI Threshold | BMI ≥ 35, or BMI ≥ 27 with at least one weight-related comorbidity |
| Insurance | Active Medicare Part D enrollment |
| Prescription | Valid prescription from a licensed provider |
| Documentation | Weight-related comorbidity documentation (if BMI 27–34.9) |
Common qualifying comorbidities include: Type 2 diabetes, hypertension, dyslipidemia (high cholesterol), obstructive sleep apnea, cardiovascular disease, and osteoarthritis.
Cost Comparison: Before and After
| Scenario | Before July 2026 | After July 2026 |
|---|---|---|
| Wegovy Injectable (self-pay) | $349/mo | ~$50/mo (if Bridge covers) |
| Zepbound KwikPen (self-pay) | $449/mo | ~$50/mo (Bridge) |
| Foundayo (self-pay) | From $149/mo | ~$50/mo (if Bridge covers) |
| Ozempic (off-label, self-pay) | $349/mo | ~$274/mo negotiated (Jan 2027) |
How to Prepare Now
Step 1: Confirm your Part D plan details. Contact your plan or check Medicare.gov to understand your current formulary and what changes take effect July 1.
Step 2: Document your comorbidities. If your BMI is between 27 and 34.9, you'll need documented weight-related comorbidities to qualify. Schedule a visit with your primary care provider to ensure your medical records reflect these conditions.
Step 3: Explore the OSA pathway now. If you have or suspect obstructive sleep apnea, Zepbound already has Part D coverage for this indication. A sleep study documenting moderate-to-severe OSA could unlock coverage today — don't wait until July.
Step 4: Don't stop current treatment. If you're already self-paying for a GLP-1, continue your current program until the Bridge kicks in. Gaps in treatment can lead to weight regain and require re-titration.